Online brief advice for heavy cannabis users
Official title: Randomised-Controlled Trial of an Online Brief Advice Intervention for Heavy Cannabis Users (RECALIBRATE)
Run by King's College London · NCT07379736 · Data updated 2026-11-12
This project will see if a short online video plus personalized feedback about cannabis withdrawal helps daily cannabis users better understand their use and withdrawal symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | King's College London Academic / other |
| Locations | 1 site (London, Greater London) |
| Status | Recruiting |
| Started | October 16, 2025 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | January 30, 2026 |
| Trial ID | NCT07379736 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are adults (18+) who use cannabis daily or near-daily (25+ days/month and ≥3.5 g/week), are fluent in English, and are not prescribed medical cannabis.
✕Probably not a fit
People using prescribed medical cannabis, infrequent cannabis users, or those who cannot read English or lack internet access are unlikely to benefit from or qualify for this online intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled experiment compares a short educational video about cannabis withdrawal plus personalized feedback on the Cannabis Withdrawal Scale to a control condition of a relaxation video and a mood questionnaire. The investigators plan to recruit at least 100 daily or near-daily cannabis users through the Prolific online platform, who will complete a brief screening and a single 10–15 minute online session including baseline measures and the assigned condition. Eligible participants are adults over 18 who use cannabis 25+ days per month and at least 3.5 g per week, fluent in English, and not prescribed medical cannabis. Primary outcomes center on awareness and insight about cannabis use disorder and withdrawal measured immediately after the intervention.
Why it matters
Potential benefit: If successful, the intervention could help daily users recognize withdrawal signs and motivate reduced use or help-seeking through a scalable online tool.
How similar studies have gone: Related digital brief interventions and personalized feedback approaches for substance use have produced modest improvements in awareness and short-term use reductions, but withdrawal-focused online interventions for heavy cannabis users are less extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (\>18 years) * Daily/near daily cannabis users (25+ days/month, min. 3.5g/week) * Sufficiently fluent in English Exclusion Criteria: * Participant is prescribed medical cannabis by a healthcare professional
Where it's running
-
Denmark Hill
London, Greater London, United Kingdom Recruiting
Study contacts
- Study coordinator: Edward Chesney, MRCPsych
- Email: edward.chesney@kcl.ac.uk
- Phone: 02078365454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of exercise on brain function in chronic cannabis users
This study is testing how exercise affects brain function and health in people who regularly use cannabis compared to those who don't.
-
Improved method to measure bone blood flow with total-body PET/CT in healthy adults
This study tests whether a whole-body PET/CT scan using a safe radioactive tracer can measure bone blood flow in healthy volunteers aged over 50.
-
Arterial stiffness in children and young people with CKD and hypertension
This study will test whether arterial stiffness is higher in children and young people with chronic kidney disease and high blood pressure compared with their peers, using a one-time assessment and follow-up for those with high BP.
-
Colchicine in dialysis patients: a feasibility test
This study tests whether a low daily dose of colchicine is tolerable for adults on haemodialysis over 3 months.
-
Cannabis-based cannabinoids and sleep-restricted stress study in healthy adults
This study tests whether THC, CBD, or a combination can influence stress and arousal in sleep-deprived healthy adults who report higher anxiety.
-
Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?
A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.